ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2532

Characteristics of Primary Sjögren Syndrome in the Black Population of Martinique

Katlyne Polomat1, Serge Arfi2, Lauren Brunier-Agot3, Véronique Dehlinger4, Michel DeBandt3, Georges Jean Baptiste5 and Christophe Deligny6, 1Centre Hospitalier universitaire de Fort de France, Fort de France, Martinique, 2Rhumatologie Et Médecine Interne, Centre hospitalier Universitaire de Fort de France, Fort de France, Martinique, 3Rheumatology, Centre Hospitalier universitaire de Fort de France, Fort de France, Martinique, 4Rheumatology, Centre Hospitalier universitaire de Fort de France, Fort De France - Martinique, Martinique, 5Rheumatology, Centre Hospitalier Universitaire de Fort de France, Fort de France, Guadeloupe, 6Internal Medicine, CHU Fort de France, Fort de France, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and ethnic studies

  • Tweet
  • Email
  • Print
Session Information

Title: Sjogren's Syndrome: Clinical Science

Session Type: Abstract Submissions (ACR)

Background/Purpose: There is very limited data on the clinical, biological characteristics and evolution of primary Sjögren syndrome (pSS)  in black patients of African origin. And yet, other connective tissue diseases such as lupus have particularities in this population.

Methods: Retrospective study of all pSS patients fullfiling American-European consensus criteria  followed as out and in patients in the rheumatology and internal medicine units from the academic hospital of Fort de France, Martinique.

Results: 70 patients were recruited since 1991 : 68 women, 2 men (female:male ratio, 34:1). Mean age at diagnosis was 49.5 yo (range: 17- 74). Mean follow up time was 3.5 years (range 1-17). Main characteristics were: xerostomia 82.8 % (n = 58) , xerophtalmia 91.4 % (n=64). Objective ocular tests were found positive in 70.3 % (n= 45/64). The minor salivary gland biopsy was positive in 92.5 % (n = 62/67). Other characteristics were: Raynaud’s phenomenon 29.8 % (n = 20/67), arthralgia 55.7 % (n=39), arthritis 21.4 % (n= 15), interstitial lung diseases 8.5 % (n= 6), peripheral neuropathy 8.5 % (n=6), central nervous system involvement 5.7 % (n = 4), pericarditis  1.4% (n=1), pleurisy 2.8 %(n =2), vasculitis 1.4 % (n =1), no pancreatitis. Some other auto-immune diseases were associated to pSS: anti-phospholipid syndrome 7.1 % (n =5), thyroiditis  7.1% (n =5), Evans syndrome 1.4 % (n =1). Antinuclear antibodies were positive for 86.9 %, anti-SSA for 62.8 % (n=44). ESR or c reactive protein  were elevated in 33 patients (47.1 %). HTLV-1 positivity was present in 2 patients. In 245 patients. years of follow up, 1 patient experienced lymphoma (0.4 lymphoma for 100 patients.years of follow up). No death was to deplore.

Conclusion: This is the first series of pSS available concerning patients of African origin. Compared to the largest Caucasian pSS cohort published by Ramos Casals et al, there seems to be no major particularities, but men are less frequently suffering from pSS and vasculitis seems less frequent than in the Caucasians.


Disclosure:

K. Polomat,
None;

S. Arfi,
None;

L. Brunier-Agot,
None;

V. Dehlinger,
None;

M. DeBandt,
None;

G. Jean Baptiste,
None;

C. Deligny,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristics-of-primary-sjogren-syndrome-in-the-black-population-of-martinique/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology